Search

Richelle G. Shelton

Examiner (ID: 3810, Phone: (571)272-7960 , Office: P/2916 )

Most Active Art Unit
2916
Art Unit(s)
2916, 2902, 2912
Total Applications
2267
Issued Applications
2226
Pending Applications
0
Abandoned Applications
41

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10300215 [patent_doc_number] => 20150185215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'Cell-Based Assays For Post-Translational Enzyme Activity' [patent_app_type] => utility [patent_app_number] => 14/412454 [patent_app_country] => US [patent_app_date] => 2013-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26068 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412454 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/412454
Cell-Based Assays For Post-Translational Enzyme Activity Jun 30, 2013 Abandoned
Array ( [id] => 13076505 [patent_doc_number] => 10058306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-28 [patent_title] => Method for obtaining fetal cells and fetal cellular components [patent_app_type] => utility [patent_app_number] => 14/410508 [patent_app_country] => US [patent_app_date] => 2013-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 39 [patent_no_of_words] => 15993 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410508 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/410508
Method for obtaining fetal cells and fetal cellular components Jun 23, 2013 Issued
Array ( [id] => 10362840 [patent_doc_number] => 20150247845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'METHOD AND A SYSTEM FOR QUANTITATIVE OR QUALITATIVE DETERMINATION OF A TARGET COMPONENT' [patent_app_type] => utility [patent_app_number] => 14/409703 [patent_app_country] => US [patent_app_date] => 2013-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16832 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409703 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/409703
Method and a system for quantitative or qualitative determination of a target component Jun 20, 2013 Issued
Array ( [id] => 9121344 [patent_doc_number] => 20130288266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'DETECTION OF A POSTTRANSLATIONALLY MODIFIED POLYPEPTIDE BY A BI-VALENT BINDING AGENT' [patent_app_type] => utility [patent_app_number] => 13/923618 [patent_app_country] => US [patent_app_date] => 2013-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 28539 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923618 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/923618
DETECTION OF A POSTTRANSLATIONALLY MODIFIED POLYPEPTIDE BY A BI-VALENT BINDING AGENT Jun 20, 2013 Abandoned
Array ( [id] => 9121345 [patent_doc_number] => 20130288267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'DETECTION OF A POLYPEPTIDE DIMER BY A BIVALENT BINDING AGENT' [patent_app_type] => utility [patent_app_number] => 13/923646 [patent_app_country] => US [patent_app_date] => 2013-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 31737 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923646 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/923646
DETECTION OF A POLYPEPTIDE DIMER BY A BIVALENT BINDING AGENT Jun 20, 2013 Abandoned
Array ( [id] => 14425219 [patent_doc_number] => 10317408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Method for quantifying immune cells in tumoral tissues and its applications [patent_app_type] => utility [patent_app_number] => 14/407698 [patent_app_country] => US [patent_app_date] => 2013-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 8209 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 340 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407698 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/407698
Method for quantifying immune cells in tumoral tissues and its applications Jun 13, 2013 Issued
13/883741 BIOMARKERS AND THERAPEUTIC TARGETS FOR TREATING CARDIOMYOPATHIES AND CONGESTIVE HEART FAILURE Jun 11, 2013 Abandoned
Array ( [id] => 10292252 [patent_doc_number] => 20150177251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'METHOD FOR DETECTING AND/OR ASSAYING ANNEXIN A3 FROM A MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/405970 [patent_app_country] => US [patent_app_date] => 2013-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19138 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405970 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/405970
METHOD FOR DETECTINGAND/OR ASSAYING ANNEXIN A3 FROMA MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF Jun 4, 2013 Abandoned
Array ( [id] => 10292252 [patent_doc_number] => 20150177251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'METHOD FOR DETECTING AND/OR ASSAYING ANNEXIN A3 FROM A MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/405970 [patent_app_country] => US [patent_app_date] => 2013-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19138 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405970 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/405970
METHOD FOR DETECTING AND/OR ASSAYING ANNEXIN A3 FROM A MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF Jun 4, 2013 Abandoned
Array ( [id] => 10263251 [patent_doc_number] => 20150148248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'MMP2 AS A PREDICTIVE BIOMARKER OF RESPONSE TO ANTIANGIOGENIC THERAPY AND SURVIVAL AFTER THERAPY IN CANCER PATIENTS' [patent_app_type] => utility [patent_app_number] => 14/402913 [patent_app_country] => US [patent_app_date] => 2013-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9215 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402913 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/402913
MMP2 AS A PREDICTIVE BIOMARKER OF RESPONSE TO ANTIANGIOGENIC THERAPY AND SURVIVAL AFTER THERAPY IN CANCER PATIENTS May 22, 2013 Abandoned
Array ( [id] => 9785706 [patent_doc_number] => 20140302527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'TARGET-SPECIFIC PROBE COMPRISING FERRITIN PROTEIN AND DETECTION FOR BIOMARKER USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/899830 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5405 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899830 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/899830
TARGET-SPECIFIC PROBE COMPRISING FERRITIN PROTEIN AND DETECTION FOR BIOMARKER USING THE SAME May 21, 2013 Abandoned
Array ( [id] => 9262648 [patent_doc_number] => 20130344577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'LIQUID CRYSTAL BASED SENSOR DEVICES FOR DETECTING TOXINS, BACTERIA AND THEIR ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 13/893607 [patent_app_country] => US [patent_app_date] => 2013-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14088 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893607 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/893607
LIQUID CRYSTAL BASED SENSOR DEVICES FOR DETECTING TOXINS, BACTERIA AND THEIR ACTIVITIES May 13, 2013 Abandoned
Array ( [id] => 10256279 [patent_doc_number] => 20150141276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'IN VITRO METHOD FOR DIAGNOSIS OF ENDOMETRIOSIS' [patent_app_type] => utility [patent_app_number] => 14/400884 [patent_app_country] => US [patent_app_date] => 2013-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5925 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400884 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/400884
IN VITRO METHOD FOR DIAGNOSIS OF ENDOMETRIOSIS May 12, 2013 Abandoned
Array ( [id] => 10240879 [patent_doc_number] => 20150125874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'TRANSIENT FLOW ASSAY' [patent_app_type] => utility [patent_app_number] => 14/398327 [patent_app_country] => US [patent_app_date] => 2013-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7090 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398327 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/398327
TRANSIENT FLOW ASSAY May 1, 2013 Abandoned
Array ( [id] => 10477485 [patent_doc_number] => 20150362502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'RAPID TEST FOR CELLULAR FIBRONECTIN' [patent_app_type] => utility [patent_app_number] => 14/391883 [patent_app_country] => US [patent_app_date] => 2013-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7249 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391883 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/391883
RAPID TEST FOR CELLULAR FIBRONECTIN Apr 10, 2013 Abandoned
Array ( [id] => 12411729 [patent_doc_number] => 09970847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Method for staining tissue [patent_app_type] => utility [patent_app_number] => 14/387730 [patent_app_country] => US [patent_app_date] => 2013-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13564 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14387730 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/387730
Method for staining tissue Mar 25, 2013 Issued
Array ( [id] => 15424457 [patent_doc_number] => 10545150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-28 [patent_title] => Lung cancer molecular markers [patent_app_type] => utility [patent_app_number] => 14/388791 [patent_app_country] => US [patent_app_date] => 2013-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 13 [patent_no_of_words] => 9757 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388791 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/388791
Lung cancer molecular markers Mar 19, 2013 Issued
Array ( [id] => 9134484 [patent_doc_number] => 20130295198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'METHODS OF SCREENING CHEMOTHERAPEUTIC AGENTS AND TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/847292 [patent_app_country] => US [patent_app_date] => 2013-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 14453 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847292 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/847292
Methods of screening chemotherapeutic agents and treating cancer Mar 18, 2013 Issued
Array ( [id] => 9737307 [patent_doc_number] => 20140273024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'SYSTEM AND METHOD FOR DETERMINING RISK OF DIABETES BASED ON BIOCHEMICAL MARKER ANALYSIS' [patent_app_type] => utility [patent_app_number] => 13/836256 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9239 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13836256 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/836256
System and method for determining risk of diabetes based on biochemical marker analysis Mar 14, 2013 Issued
Array ( [id] => 9737306 [patent_doc_number] => 20140273025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'SYSTEM AND METHOD FOR DETERMINING RISK OF PRE-ECLAMPSIA BASED ON BIOCHEMICAL MARKER ANALYSIS' [patent_app_type] => utility [patent_app_number] => 13/837134 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9598 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13837134 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/837134
SYSTEM AND METHOD FOR DETERMINING RISK OF PRE-ECLAMPSIA BASED ON BIOCHEMICAL MARKER ANALYSIS Mar 14, 2013 Abandoned
Menu